EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, LigaChem Biosciences's enterprise value is ₩1,805,975 Mil.
LigaChem Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩57,543 Mil. Therefore, LigaChem Biosciences's EV-to-Revenue for today is 31.38.
The historical rank and industry rank for LigaChem Biosciences's EV-to-Revenue or its related term are showing as below:
XKRX:141080'
s EV-to-Revenue Range Over the Past 10 Years
Min: 7.86 Med: 27.27 Max: 527.14
Current: 31.38
During the past 12 years, the highest EV-to-Revenue of LigaChem Biosciences was 527.14. The lowest was 7.86. And the median was 27.27.
XKRX:141080's EV-to-Revenue is ranked worse than 78.45% of 1044
companies
in the Biotechnology industry
Industry Median: 8.205
vs XKRX:141080: 31.38
LigaChem Biosciences EV-to-Revenue Historical Data
The historical data trend for LigaChem Biosciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of LigaChem Biosciences's EV-to-Revenue
For the Biotechnology subindustry, LigaChem Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LigaChem Biosciences's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, LigaChem Biosciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where LigaChem Biosciences's EV-to-Revenue falls into.
LigaChem Biosciences's current Enterprise Value is ₩1,805,975 Mil.
LigaChem Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩57,543 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LigaChem Biosciences's share price for today is ₩68700.00.
LigaChem Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,004.51.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LigaChem Biosciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of LigaChem Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
LigaChem Biosciences (XKRX:141080) Business Description
LegoChem Biosciences Inc develops new drugs through research. The Company provides business research services, manufacturing and sale of compounds, and drug evaluation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:141080 has been successfully added to your 